Cargando…

The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis

Detalles Bibliográficos
Autores principales: Del Rio-Pertuz, Gaspar, Benjanuwattra, Juthipong, Phinyo, Phichayut, Leelaviwat, Natnicha, Mekraksakit, Poemlarp, Nair, Nandini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Heart Failure 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172078/
https://www.ncbi.nlm.nih.gov/pubmed/37180559
http://dx.doi.org/10.36628/ijhf.2022.0034
_version_ 1785039552308576256
author Del Rio-Pertuz, Gaspar
Benjanuwattra, Juthipong
Phinyo, Phichayut
Leelaviwat, Natnicha
Mekraksakit, Poemlarp
Nair, Nandini
author_facet Del Rio-Pertuz, Gaspar
Benjanuwattra, Juthipong
Phinyo, Phichayut
Leelaviwat, Natnicha
Mekraksakit, Poemlarp
Nair, Nandini
author_sort Del Rio-Pertuz, Gaspar
collection PubMed
description
format Online
Article
Text
id pubmed-10172078
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Society of Heart Failure
record_format MEDLINE/PubMed
spelling pubmed-101720782023-05-12 The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis Del Rio-Pertuz, Gaspar Benjanuwattra, Juthipong Phinyo, Phichayut Leelaviwat, Natnicha Mekraksakit, Poemlarp Nair, Nandini Int J Heart Fail Letter Korean Society of Heart Failure 2023-03-07 /pmc/articles/PMC10172078/ /pubmed/37180559 http://dx.doi.org/10.36628/ijhf.2022.0034 Text en Copyright © 2023. Korean Society of Heart Failure https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Del Rio-Pertuz, Gaspar
Benjanuwattra, Juthipong
Phinyo, Phichayut
Leelaviwat, Natnicha
Mekraksakit, Poemlarp
Nair, Nandini
The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
title The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
title_full The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
title_fullStr The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
title_full_unstemmed The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
title_short The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
title_sort mortality benefit of milrinone as a continuous outpatient intravenous inotrope therapy in advanced heart failure: a systemic review and meta-analysis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172078/
https://www.ncbi.nlm.nih.gov/pubmed/37180559
http://dx.doi.org/10.36628/ijhf.2022.0034
work_keys_str_mv AT delriopertuzgaspar themortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT benjanuwattrajuthipong themortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT phinyophichayut themortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT leelaviwatnatnicha themortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT mekraksakitpoemlarp themortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT nairnandini themortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT delriopertuzgaspar mortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT benjanuwattrajuthipong mortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT phinyophichayut mortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT leelaviwatnatnicha mortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT mekraksakitpoemlarp mortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis
AT nairnandini mortalitybenefitofmilrinoneasacontinuousoutpatientintravenousinotropetherapyinadvancedheartfailureasystemicreviewandmetaanalysis